Structure-Based Affinity Neural Network for Peptide MHC Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack effective means to predict the affinity of potential neoantigens for antigen presenting molecules like MHC proteins, which is crucial for successful therapeutic vaccination in cancer immunotherapy.
Innovation Solution
The method involves obtaining a three-dimensional structural representation of candidate molecules bound to antigen presenting molecules, generating multiple measurements associated with structural features, and using an electronic processor to predict affinity based on these measurements through a structure-based affinity neural network.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If structure-based affinity prediction methods are implemented, then prediction accuracy is improved, but device complexity and computational requirements increase
Solution Approach 1:
The system performs preliminary structural modeling of peptide-MHC complexes using computational tools (Rosetta, PDB2PQR, MMPBSA.py) before affinity prediction. This pre-computation of structural representations and energy calculations prepares the data in advance, enabling more accurate affinity predictions without increasing the complexity of the prediction algorithm itself.
Solution Approach 2:
The patent introduces intermediate computational steps and tools as mediators between the input peptide sequence and the final affinity prediction. These include structural modeling intermediates, energy calculation intermediates (MM-PBSA), and data processing intermediates that bridge the gap between raw structural data and affinity values, improving accuracy while managing system complexity through modular architecture.
2Reliability
If comprehensive structural modeling and multiple measurements are used, then prediction reliability is improved, but computational time and resources increase
Solution Approach 1:
The system performs structural modeling and energy calculations in advance before the actual affinity prediction. By pre-computing the structural representations and MM-PBSA energy values, the system ensures reliable prediction data is available without requiring extensive computational time during the prediction phase itself.
Solution Approach 2:
The patent replaces traditional experimental affinity measurement methods with computational modeling and simulation approaches. This substitution uses in silico structural modeling and energy calculations to predict affinity, providing reliable results without the time-consuming nature of wet-lab experiments while maintaining scientific rigor through physics-based computational methods.
Data Source
AI summary
Described are methods for predicting affinity of a candidate molecule for a second molecule. The method comprises obtaining a three-dimensional candidate structural representation of the candidate molecule bound to a second molecule; obtaining a plurality of candidate measurements, wherein each candidate measurement is associated with at least one feature of the candidate structural representation; and predicting, with an electronic processor, the affinity of the candidate molecule for the second molecule, wherein the electronic processor is configured to predict the affinity of the candidate molecule for the second molecule based upon the plurality of candidate measurements. The candidate molecule may be a peptide, such as a neoantigen, a viral peptide, a non-mutated self peptide, or a post-translationally modified peptide. The second molecule may be an antigen presenting molecule, such as a class I MHC molecule or a class II MHC molecule.